News | October 07, 2023
Emmes acquires VaxTRIALS
VaxTRIALS Adds a New Latin America Base and Greater Vaccine Research Depth
VaxTRIALS Adds a New Latin America Base and Greater Vaccine Research Depth
This integrated care offering is a step forward in our vision of providing an effective continuum of care for patients
The extension builds upon an existing long-term collaboration for end-to-end ADC manufacturing, including payload, monoclonal antibody (mAb) manufacturing and bioconjugation
The approval adds to a list of products that Strides has approved in this therapeutic category through the PEPFAR pathway taking the total to 15 products
The product is an additional formulation of Cresemba Capsule 100 mg and Cresemba Intravenous Infusion 200 mg
The company has received six final approvals that includes Chlorpromazine Hydrochloride Tablets
SigTuple’s AI100 with Shonit is the premier solution for AI assisted digital pathology
Aim is to treat Dyslipidemia by inhibiting PCSK9 with a novel entity
Balaxi Healthcare Ecuador S.A.S. has become a Wholly Owned Subsidiary of the company
New Board of Directors and management team at Suven Pharma also appointed
Subscribe To Our Newsletter & Stay Updated
